1-5 of 5
Matthew D. Hall
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

GPC1-Targeted Immunotoxins Inhibit Pancreatic Tumor Growth in Mice via Depletion of Short-lived GPC1 and Downregulation of Wnt Signaling

Jiajia Pan, Nan Li, Alex Renn, Hu Zhu, Lu Chen, Min Shen, Matthew D. Hall, Min Qian, Ira Pastan, Mitchell Ho
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (6): 960–973.
https://doi.org/10.1158/1535-7163.MCT-21-0778
Published: 01 June 2022
View article titled, GPC1-Targeted Immunotoxins Inhibit Pancreatic Tumor Growth in Mice via Depletion of Short-lived GPC1 and Downregulation of Wnt Signaling
Open the PDF for GPC1-Targeted Immunotoxins Inhibit Pancreatic Tumor Growth in Mice via Depletion of Short-lived GPC1 and Downregulation of Wnt Signaling in another window
Includes: Supplementary data
Journal Articles

KDM5B Promotes Drug Resistance by Regulating Melanoma-Propagating Cell Subpopulations

Xiaoni Liu, Shang-Min Zhang, Meaghan K. McGeary, Irina Krykbaeva, Ling Lai, Daniel J. Jansen, Stephen C. Kales, Anton Simeonov, Matthew D. Hall, Daniel P. Kelly, Marcus W. Bosenberg, Qin Yan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (3): 706–717.
https://doi.org/10.1158/1535-7163.MCT-18-0395
Published: 01 March 2019
View article titled, KDM5B Promotes Drug Resistance by Regulating Melanoma-Propagating Cell Subpopulations
Open the PDF for KDM5B Promotes Drug Resistance by Regulating Melanoma-Propagating Cell Subpopulations in another window
Includes: Supplementary data
Journal Articles

The Protein Phosphatase 2A Inhibitor LB100 Sensitizes Ovarian Carcinoma Cells to Cisplatin-Mediated Cytotoxicity

Ki-Eun Chang, Bih-Rong Wei, James P. Madigan, Matthew D. Hall, R. Mark Simpson, Zhengping Zhuang, Michael M. Gottesman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (1): 90–100.
https://doi.org/10.1158/1535-7163.MCT-14-0496
Published: 13 January 2015
View article titled, The Protein Phosphatase 2A Inhibitor LB100 Sensitizes Ovarian Carcinoma Cells to Cisplatin-Mediated Cytotoxicity
Open the PDF for The Protein Phosphatase 2A Inhibitor LB100 Sensitizes Ovarian Carcinoma Cells to Cisplatin-Mediated Cytotoxicity in another window
Includes: Supplementary data
Journal Articles

Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters

Mitsunori Okabe, Gergely Szakács, Mark A. Reimers, Toshihiro Suzuki, Matthew D. Hall, Takaaki Abe, John N. Weinstein, Michael M. Gottesman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (9): 3081–3091.
https://doi.org/10.1158/1535-7163.MCT-08-0539
Published: 11 September 2008
View article titled, Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
Open the PDF for Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters in another window
Includes: Supplementary data
Journal Articles

Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance–linked ABCG2 transporter

Chung-Pu Wu, Suneet Shukla, Anna Maria Calcagno, Matthew D. Hall, Michael M. Gottesman, Suresh V. Ambudkar
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (12): 3287–3296.
https://doi.org/10.1158/1535-7163.MCT-07-2005
Published: 18 December 2007
View article titled, Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance–linked ABCG2 transporter
Open the PDF for Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance–linked ABCG2 transporter in another window